Skip to main content
Terug
Watch Compare

Atrium Therapeutics, Inc.

Datakwaliteit: 17%
RNA
Nasdaq Manufacturing Chemicals
€ 12,71
▼ € 1,01 (-7,36%)
Marktkapitalisatie: 211,93 M
Prijs
€ 13,66
Marktkapitalisatie
211,93 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Waardering

P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E — -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

1 analist
Buy
Huidig
€ 12,71
+96.7%
Koersdoel
€ 25,00
€ 25,00
€ 25,00
€ 25,00
Vooruitzicht
Forward WPA -€ 4,62
Omzet Sch. 8,00 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 4,62
-€ 4,62 – -€ 4,62
 8,00 M 1
FY2026 -€ 4,14
-€ 4,14 – -€ 4,14
 8,00 M 1

ETFs Holding This Stock

MNTL MNTL
1,72% weight
JFNIX JFNIX
1,58% weight
JFNCX JFNCX
1,58% weight
JFNSX JFNSX
1,58% weight
JFNNX JFNNX
1,58% weight
JNGLX JNGLX
1,58% weight
JFNAX JFNAX
1,58% weight
JAGLX JAGLX
1,58% weight
JVTSX JVTSX
1,23% weight
JVTIX JVTIX
1,23% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 211,93 M Enterprise Value N/A
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A